muscarine receptors

  1. John Mac

    Trial Report Effect on QoL of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of ME/CFS Patients, 2025, Oesch-Regeni

    Full title: The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies—A Pilot Study...
  2. Ravn

    PREVAIL Proof-of-Concept Study of TNX-102 SL for FM-Type Long COVID

    Media story Full headline: Tonix Pharmaceuticals Completes Clinical Phase of PREVAIL Proof-of-Concept Study of TNX-102 SL for the Treatment of Fibromyalgia-Type Long COVID https://finance.yahoo.com/news/tonix-pharmaceuticals-completes-clinical-phase-110000281.html
  3. V

    Winsantor Phase 2 small fiber neuropathy drug (WST-057) trial news.

    I recieved this newsletter and could not find it posted on the Internet, so I thought I’d post the text. This is a newsletter from a small company, Winsantor, who is testing a topical drug (WST-057) to see if it increases small fiber nerve density (and improve symptoms?) in diabetic patients...
  4. SNT Gatchaman

    Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome, 2022, Gravelsina et al

    Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome Gravelsina Sabine, Vilmane Anda, Svirskis Simons, Rasa-Dzelzkaleja Santa, Nora-Krukle Zaiga, Vecvagare Katrine, Krumina Angelika, Leineman Iana, Shoenfeld Yehuda, Murovska Modra Myalgic...
Back
Top Bottom